ConductScience.org, home

Paper20157366

Probiotic Pre-treatment Reduces Gliclazide Permeation (ex vivo) in Healthy Rats but Increases It in Diabetic Rats to the Level Seen in Untreated Healthy Rats.

Al-Salami H and 5 others. Arch Drug Inf, 2008. Cited by 48 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Probiotic Pre-treatment Reduces Gliclazide Permeation (ex vivo) in Healthy Rats but Increases It in Diabetic Rats to the Level Seen in Untreated Healthy Rats. Papers, record 20157366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20157366

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Probiotic Pre-treatment Reduces Gliclazide Permeation (ex vivo) in Healthy Rats but Increases It in Diabetic Rats to the Level Seen in Untreated Healthy Rats.
PubMed
Journal
Arch Drug Inf
PubMed
Year
2008
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
48
iCite
Relative citation ratio, by iCite
1.52
iCite
Revised in PubMed
2021-10-20
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Al-Salami HHani
2Butt GGrant
3Tucker IIan
4Skrbic RRanko
5Golocorbin-Kon SSvetlana
6Mikov MMomir

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References41

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112,554,153A simple and sensitive HPLC method for determination of gliclazide in human serum.J Chromatogr B Analyt Technol Biomed Life Sci2003https://conductscience.org/library/papers/12554153PubMed
210,767,599Absorption of angiotensin II antagonists in Ussing chambers, Caco-2, perfused jejunum loop and in vivo: importance of drug ionisation in the in vitro prediction of in vivo absorption.Eur J Pharm Sci2000https://conductscience.org/library/papers/10767599PubMed
39,721,312Multidrug efflux pump AcrAB of Salmonella typhimurium excretes only those beta-lactam antibiotics containing lipophilic side chains.J Bacteriol1998https://conductscience.org/library/papers/9721312PubMed
412,939,737Gliclazide modified release: A critical review of pharmacodynamic, metabolic, and vasoprotective effects.Metabolism2003https://conductscience.org/library/papers/12939737PubMed
511,157,348Probiotics: determinants of survival and growth in the gut.Am J Clin Nutr2001https://conductscience.org/library/papers/11157348PubMed
614,706,810The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability.Eur J Pharm Sci2004https://conductscience.org/library/papers/14706810PubMed
717,200,703The role of gut hormones in glucose homeostasis.J Clin Invest2007https://conductscience.org/library/papers/17200703PubMed
81,794,262The mode of action and clinical pharmacology of gliclazide: a review.Diabetes Res Clin Pract1991https://conductscience.org/library/papers/1794262PubMed
915,352,898Review article: antibiotics and probiotics in inflammatory bowel disease.Aliment Pharmacol Ther2004https://conductscience.org/library/papers/15352898PubMed
109,200,314Role of animal models for the pathogenesis and treatment of inflammatory bowel disease.Scand J Gastroenterol Suppl1997https://conductscience.org/library/papers/9200314PubMed
1112,675,685Lactobacillus rhamnosus GG decreases TNF-alpha production in lipopolysaccharide-activated murine macrophages by a contact-independent mechanism.Cell Microbiol2003https://conductscience.org/library/papers/12675685PubMed
1215,529,516Cardiovascular effects of treatment of type 2 diabetes with pioglitazone, metformin and gliclazide.Int J Clin Pract2004https://conductscience.org/library/papers/15529516PubMed
138,732,950Scaling basic toxicokinetic parameters from rat to man.Environ Health Perspect1996https://conductscience.org/library/papers/8732950PubMed
1415,200,348The role of sulphonylureas in the management of type 2 diabetes mellitus.Drugs2004https://conductscience.org/library/papers/15200348PubMed
1511,073,816The effect of rifampin treatment on intestinal expression of human MRP transporters.Am J Pathol2000https://conductscience.org/library/papers/11073816PubMed
1614,566,382Probiotics: Isolated bacteria strain or mixtures of different strains? Two different approaches in the use of probiotics as therapeutics.Drugs Today (Barc)2003https://conductscience.org/library/papers/14566382PubMed
17401,727Drug interactions with oral sulphonylurea hypoglycaemic drugs.Drugs1977https://conductscience.org/library/papers/401727PubMed
1815,111,555Glycemic treatment: Control of glycemia.Diabetes Care2004https://conductscience.org/library/papers/15111555PubMed
1917,077,077Safety of probiotics.Asia Pac J Clin Nutr2006https://conductscience.org/library/papers/17077077PubMed
2015,721,033Amendments to the theory underlying Ussing chamber data of chloride ion secretion after bacterial enterotoxin exposure.J Theor Biol2005https://conductscience.org/library/papers/15721033PubMed

See all 41 references

Cited by28

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 48 citations.

PMIDTitleJournalYearIn PapersSource
42,707,375Pharmacomicrobiomics in metabolic syndrome and type 2 diabetes: the microbiome-drug-host triad.Front Pharmacol2026https://conductscience.org/library/papers/42707375PubMed
40,634,920Probiotic preserving extract supplementation as a novel attitude in managing diabetes mellitus.BMC Complement Med Ther2025https://conductscience.org/library/papers/40634920PubMed
38,789,535Computational prediction of new therapeutic effects of probiotics.Sci Rep2024https://conductscience.org/library/papers/38789535PubMed
35,203,519The Relationships between Gut Microbiota and Diabetes Mellitus, and Treatments for Diabetes Mellitus.Biomedicines2022https://conductscience.org/library/papers/35203519PubMed
34,386,321The influence of the gut microbiota on the bioavailability of oral drugs.Acta Pharm Sin B2021https://conductscience.org/library/papers/34386321PubMed
34,103,897Cinnamaldehyde Improves Metabolic Functions in Streptozotocin-Induced Diabetic Mice by Regulating Gut Microbiota.Drug Des Devel Ther2021https://conductscience.org/library/papers/34103897PubMed
32,751,051Pharmacological and Advanced Cell Respiration Effects, Enhanced by Toxic Human-Bile Nano-Pharmaceuticals of Probucol Cell-Targeting Formulations.Pharmaceutics2020https://conductscience.org/library/papers/32751051PubMed
32,708,933Safety of Probiotics: Functional Fruit Beverages and Nutraceuticals.Foods2020https://conductscience.org/library/papers/32708933PubMed
32,382,021Micro-Nano formulation of bile-gut delivery: rheological, stability and cell survival, basal and maximum respiration studies.Sci Rep2020https://conductscience.org/library/papers/32382021PubMed
32,290,519Imbalance of Drug Transporter-CYP450s Interplay by Diabetes and Its Clinical Significance.Pharmaceutics2020https://conductscience.org/library/papers/32290519PubMed
31,919,411Bile acid bio-nanoencapsulation improved drug targeted-delivery and pharmacological effects via cellular flux: 6-months diabetes preclinical study.Sci Rep2020https://conductscience.org/library/papers/31919411PubMed
31,719,879
Influence of Biotechnological Processes, Speed of Formulation Flow and Cellular Concurrent Stream-Integration on Insulin Production from β-cells as a Result of Co-Encapsulation with a Highly Lipophilic Bile Acid.
Cell Mol Bioeng2018https://conductscience.org/library/papers/31719879PubMed
31,607,925Transport and Biotransformation of Gliclazide and the Effect of Deoxycholic Acid in a Probiotic Bacteria Model.Front Pharmacol2019https://conductscience.org/library/papers/31607925PubMed
30,931,309Gut Microbiota, Host Organism, and Diet Trialogue in Diabetes and Obesity.Front Nutr2019https://conductscience.org/library/papers/30931309PubMed
30,513,975Biological Activities of Lactose-Based Prebiotics and Symbiosis with Probiotics on Controlling Osteoporosis, Blood-Lipid and Glucose Levels.Medicina (Kaunas)2018https://conductscience.org/library/papers/30513975PubMed
30,319,399Bile Acid Synthesis: From Nature to the Chemical Modification and Synthesis and Their Applications as Drugs and Nutrients.Front Pharmacol2018https://conductscience.org/library/papers/30319399PubMed
29,039,071Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and Probiotics.Eur J Drug Metab Pharmacokinet2018https://conductscience.org/library/papers/29039071PubMed
28,547,295
High-Loading Dose of Microencapsulated Gliclazide Formulation Exerted a Hypoglycaemic Effect on Type 1 Diabetic Rats and Incorporation of a Primary Deconjugated Bile Acid, Diminished the Hypoglycaemic Antidiabetic Effect.
Eur J Drug Metab Pharmacokinet2017https://conductscience.org/library/papers/28547295PubMed
27,499,689Heat-killed Lactobacillus Reuteri GMNL-263 Prevents Epididymal Fat Accumulation and Cardiac Injury in High-Calorie Diet-Fed Rats.Int J Med Sci2016https://conductscience.org/library/papers/27499689PubMed
26,797,809Effect of Lactobacillus casei on the Pharmacokinetics of Amiodarone in Male Wistar Rats.Eur J Drug Metab Pharmacokinet2017https://conductscience.org/library/papers/26797809PubMed

See all 28 cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABCB15,243PubTator's text mininghttps://conductscience.org/library/genes/5243NCBI Gene
ABCC21,244PubTator's text mininghttps://conductscience.org/library/genes/1244NCBI Gene
ABCC38,714PubTator's text mininghttps://conductscience.org/library/genes/8714NCBI Gene
INS3,630PubTator's text mininghttps://conductscience.org/library/genes/3630NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20157366

GET https://conductscience.org/api/papers/v1/20157366/references?page=2